UCSF Helen Diller Comprehensive Cancer Centre - Precision Cancer Medicine Building — San Francisco, California

UCSF Helen Diller Comprehensive Cancer Centre - Precision Cancer Medicine Building is a clinical research site located in San Francisco, California, United States 94158.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

UCSF Helen Diller Comprehensive Cancer Centre - Precision Cancer Medicine Building has participated in 1 clinical trials.

Therapeutic areas: Breast Neoplasms, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCSF Helen Diller Comprehensive Cancer Centre - Precision Cancer Medicine Building?

UCSF Helen Diller Comprehensive Cancer Centre - Precision Cancer Medicine Building has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCSF Helen Diller Comprehensive Cancer Centre - Precision Cancer Medicine Building conducted?

UCSF Helen Diller Comprehensive Cancer Centre - Precision Cancer Medicine Building has 1 clinical trials on record. Their work covers Breast Neoplasms, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation.

Is UCSF Helen Diller Comprehensive Cancer Centre - Precision Cancer Medicine Building accredited by Crixeo Health?

UCSF Helen Diller Comprehensive Cancer Centre - Precision Cancer Medicine Building has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCSF Helen Diller Comprehensive Cancer Centre - Precision Cancer Medicine Building?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.